Background. The first-pass metabolism of foreign compounds in the lung is an important protective (Lancet 1997;350:630-33) 
Chronic obstructive pulmonary disease (COPD) is one emphysema can be produced experimentally by intratracheal instillation of papain, led to the protease-antiof the major causes of premature death in industrialised countries. While its primary pathology is pulmonary protease hypothesis of pulmonary emphysema. The introductory article contributes further to the emphysema together with narrowing and obliteration of airways, COPD remains a clinical diagnosis chardebate. It suggests that genetic susceptibility to oxidative stress may also confer a risk for the development of acterised by chronic airflow limitation which progresses slowly over a period of years and is largely irreversible. 1 COPD. This implies that oxidant-antioxidant imbalance, like protease-antiprotease imbalance, may be The majority of cases are a consequence of chronic cigarette smoking and are thus preventable. However, important in its pathogenesis. 8 Indeed, a number of investigators have implicated oxidant-antioxidant interonly a relatively small proportion of smokers develop symptomatic disease. 2 As a consequence, there has been action in the pathogenesis of smoking induced COPD. 9 10 In brief, smoking increases alveolar oxidants, considerable interest in identifying those who are most susceptible, and the mechanisms of their susceptibility.
in part because cigarette smoke itself contains an enormous number of free radicals and in part because it A number of studies indicate that genetic factors contribute to the risk of COPD. Alpha 1 -antitrypsin deincreases the number of inflammatory cells in alveoli which spontaneously release oxidants. These oxidants ficiency is already well recognised and twin studies have suggested the presence of other undetermined genetic inactivate 1 -antitrypsin and other protease inhibitors such as secretory leukoprotease inhibitor. Furthermore, factors. [3] [4] [5] [6] Identification of these genetic components could provide useful insights into the pathogenesis of the recruited inflammatory cells also increase the protease burden, thus tipping the protease-antiprotease COPD in the same way as did recognition of the association between 1 -antitrypsin deficiency and balance further towards the protease side. Moreover, oxidants in cigarette smoke can directly damage com-COPD. 7 This association, together with the fact that University. No clinical data were available for the lung cancer patients but lung function was presumably quite well preserved or they would not have undergone surgery. This rather odd study design suggests a possible change of direction during the course of the research. It may be that the investigators started by seeking a genetic susceptibility to lung cancer (reactive epoxides are carcinogenic) with negative results, but stumbled on an association between slow metabolisers and COPD. Whatever the primary aim, the outcome was interesting. In brief, the COPD and "emphysema" groups contained significantly more homozygous mutants for the exon 3 (slow) polymorphism than the controls. causal association, the study population was small and the findings could be due to chance. They clearly need to be confirmed in other study populations. Furthermore, the "emphysema" group was unusual, being ponents of the lung extracellular matrix such as elastin and collagen, or modify the matrix to make it more defined from the morbid anatomy of lung samples resected for cancer. While this is the "purest" way to susceptible to protease attack (fig 1) .
The systemic effects of these changes can be detected make such a diagnosis, it provides no clinical information. If these subjects simply had histological eviin a number of ways. Morrow et al have recently found increased levels of prostaglandin F 2 like compounds (F 2 -dence of mild emphysema, they may not be satisfactorily representative of smokers in general who are susceptible isoprostanes) in the plasma of smokers, indicating that smoking causes lipid peroxidation in vivo. 11 Rahman et to COPD. A second concern is whether biochemical pathways al found a decreased antioxidant capacity of plasma in smokers, the decrease being most marked one hour affected by microsomal epoxide hydrolase are actually involved in the pathogenesis of emphysema. Cigarette after smoking. Thus, cigarette smoke may deplete the antioxidant capacity. 12 There is consequently good smoke certainly contains free radicals and multiple other chemicals capable of generating reactive epoxides, and theoretical and experimental evidence, as well as some clinical support, pointing to the importance of the oxsome of these can certainly damage nucleic acids, proteins and lipids. It is not clear, however, whether these idant-antioxidant imbalance in the pathogenesis of pulmonary emphysema. In addition, there have been processes are important in vivo, how they affect the protease/antiprotease balance or oxidant/antioxidant suggestions that genetic susceptibility to oxidative stress may have a role in the pathogenesis of other diseases such balance, nor whether epoxide hydrolase is an important rate limiting step in such a process. as diabetes mellitus 13 and its vascular complications, 14 and Parkinson's disease. 15 The hypothesis that oxidant/antioxidant imbalance is due to polymorphisms of the gene for microsomal epWe shall review the introductory article in the context of all the known genetic associations of COPD.
oxide hydrolase is nevertheless an interesting one which deserves further investigation. There are many possible genetic mechanisms for undue susceptibility to cigarette smoke, and it is worth reviewing the range of these in Introductory article Smith and Harrison investigated the genetic polyorder to put this new observation in perspective. morphism of an important xenobiotic metabolising enzyme, microsomal epoxide hydrolase. There are four common microsomal epoxide hydrolase alleles, deGenetic contributions to COPD   pending on the presence or absence of two point mutations in the coding gene. The presence of one mutation Genetically determined variation in xenobiotic detoxification/biotransformation has attracted interest reresults in a "slow" allele, while the presence of the other gives rise to a "fast" allele. The rare occurrence of both cently as a possible mechanism for observed differences in susceptibility to various conditions-for example, mutations together produces the enzyme with normal activity. The homozygous state for the slow allele results idiosyncratic reactions to pharmacological agents and smoking induced lung cancers. 16 17 A detailed discussion in a phenotype of very slow microsomal epoxide hydrolase activity.
of the metabolic process of detoxification of xenobiotics is beyond the scope of this review. Briefly, the major Using a PCR-based genotyping assay, Smith and Harrison investigated whether polymorphisms in the pathway of metabolism involves two main types of enzymes: the phase I cytochrome P-450 mediating oxgene for microsomal epoxide hydrolase were linked with susceptibility to COPD and emphysema. The mechidative metabolism, and phase II conjugating enzymes such as glutathione S-transferases. A number of xenoanism proposed was that, since this enzyme system is involved in the metabolism of highly reactive epoxide biotics, including benzo[a]pyrene, a carcinogen contained in tobacco smoke, are enzymatically metabolised intermediates, slow metabolisers might experience greater oxidative stress from cigarette smoke and so to highly reactive intermediates such as epoxides by the cytochrome P450 system. These resultant metabolites develop lung disease. Four groups were studied: blood donor controls, asthma controls, patients with COPD, may be cytotoxic, mutagenic, and/or carcinogenic. The enzymatic conversion of these metabolites to inactive and patients with lung cancer. The group with lung cancer was then subdivided into those with and those intermediates is therefore protective. Epoxides can be detoxified principally by glutathione without emphysema by examination of the resection specimens from the pathology archives of Edinburgh S-transferases (GST) or epoxide hydrolases. 24 or GST P1.
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Figure 2 Xenobiotic metabolism: activation-inactivation
The expression and activity of enzymes are influenced not only by genetic factors but also by various chemicals in the environment through induction and competitive inhibition. Furthermore, the clinical effect will depend ative balance between activation and inactivation is not only on the kinetics of metabolism but also on the thought to underlie susceptibility to the noxious effects major site of action. Local expression in lungs might of various xenobiotics (fig 2) . For example, altered well be as important as hepatic metabolism, and so the phenotypes and genotypes in the cytochrome P450 relationship of the activity of a given enzyme and its isoforms CYP1A1 have been reported to be associated clinical consequences is likely to be complex. with smoking-induced lung cancer and other cancers. 18 Defective glutathione S-transferases caused by the GST M1 null genotype have also been linked to an increased risk of developing lung cancer, 19 although the results of studies conducted in different ethnic groups have not     Alpha 1 -antitrypsin deficiency always been consistent. In addition, individuals with the susceptible genotypes of CYP1A1 with deficient A number of genetic factors have been proposed to increase the risk for developing COPD, but only a few GST M1 were reported to be at remarkably high risk in a Japanese population. 20 This topic has recently been have been confirmed to be clinically significant. The most important is 1 -antitrypsin deficiency; the odds reviewed by Smith and associates 21 and Raunio et al. 22 Although the liver plays a major role in xenobiotic ratio for the development of COPD in association with the homozygous ZZ phenotype (presence versus abmetabolism, other organs (including lungs, kidneys and the gastrointestinal tract) have also been shown to be sence) has been calculated at more than 30 (table 1) . As 1 -antitrypsin is a potent inhibitor of neutrophil potential sites of metabolism. 23 The introductory article is the first to suggest the elastase, the recognition of this association has led to an elastase-antielastase hypothesis (or, more broadly, a involvement of genetic susceptibility to oxidative stress in the development of COPD. Previous studies on protease-antiprotease hypothesis) as a pathogenic explanation for pulmonary emphysema (fig 1) . However, oxidant-antioxidant imbalance in COPD have focused largely on reactive oxygen species or oxidative molecules as the frequency of this homozygosity is relatively low even in Caucasian populations, the deficiency accounts such as superoxide anion, hydrogen peroxide and hydroxyl radical, nitrogen dioxide, and ozone as the for less than 1% only of all patients with COPD, although some estimates have been higher. 26 Furthermore, offensive agents. Many have also concerned the "classic" antioxidant enzymes such as superoxide dismutase, cata-1 -antitrypsin deficiency with the PiZZ phenotype is not necessarily associated with COPD and many such lase, and glutathione peroxidase, as well as non-en- group.bmj.com on June 23, 2017 -Published by http://thorax.bmj.com/ Downloaded from people remain healthy in the absence of a smoking deficiency, and this abnormality is unlikely to account for a large proportion of patients who develop COPD. history into their sixth and seventh decades. 27 The heterozygous state of 1 -antitrypsin deficiency has also been implicated as a possible risk factor for COPD; the odds ratio for developing COPD in MZ   -  A recent study from Taiwan has reported an association heterozygotes (compared with subjects who are neither heterozygotes nor homozygotes) has been reported by between chronic bronchitis and a polymorphism at the -308 position of the tumour necrosis factor (TNF ) some investigators to range from 1.5 to 5.0 in a review by Standford et al 28 (see also table 1). Furthermore, gene. 40 This polymorphism gives rise to two alleles, TNF1 and TNF2. The investigators found that the less Tarján and colleagues have recently reported accelerated declines in expiratory flow rates and diffusing capacity, common allele, TNF2, which was associated with higher basal and induced expression of TNF , was more preas well as increases in total lung capacity and residual volume, in PiMZ heterozygous subjects in a longitudinal valent in patients with chronic bronchitis. They suggested there was an augmented inflammatory process study. 29 In practice, however, the PiMZ state has not been found to pose a major risk for COPD, especially associated with tissue injury due to increased TNF expression, and hence the development of chronic bronin the absence of smoking. Indeed, several studies in randomly selected populations have failed to demchitis.
The patient group consisted of 42 male adults who onstrate a definite association between MZ phenotype and COPD, [30] [31] [32] [33] [34] one having had a power of 95% to had histories of chronic or recurrent productive cough for more than two successive years. There was also detect a difference in FEV 1 /FVC% as low as 3%. 34 airflow limitation defined as FEV 1 of <80% predicted and FEV 1 /FVC <69% predicted. Thirteen patients (31%) were non-smokers. No occupational histories Mutation of the flanking sequence of the 1 -antitrypsin gene were given, and the 13 may have included patients with chronic asthma. Further studies in other populations A mutation of the 3′ flanking sequence of the 1 -antitrypsin gene has been associated with COPD in a will be needed to confirm this interesting association. few studies. 35 36 The odds ratios for developing COPD (or emphysema) in association with this mutation (present versus absent) were calculated to be 4.3 and 3.2,   Inherited disorders of connective tissue such as Marfan respectively. This condition is different from 1 -antitrypsin deficiency in that the sequence which codes for syndrome, 41 Ehlers-Danlos syndrome, 42 and cutis laxa 43 are reported to be associated with a number of pulthe protein itself is normal and the basal serum level of 1 -antitrypsin is not reduced. Kalsheker et al suggested monary diseases including emphysema. Abnormal elastic tissue in lungs has been found in necropsy mathat the mutation might diminish the response of the 1 -antitrypsin gene to interleukin 6 and thus suppress terial from infants with Marfan syndrome, 41 and this may explain the association. the acute phase response of 1 -antitrypsin. 37 This acute response is thought to counter the increased proteolytic Blood group-related phenotypes including ABO blood group, ABH secretor/non-secretor, and Lewis burden at the region of injury induced by inflammation.
positive/negative status have also been focuses of attention, but study results have been inconclusive. [44] [45] [46] [47] The sex and race of the subjects have also been Alpha 1 -antichymotrypsin deficiency The deficiency of another serine protease inhibitor, 1 -implicated as possible factors of relevance. The prevalences of COPD and chronic bronchitis are said to antichymotrypsin, has also been shown to be associated with COPD. This counteracts the adverse enzymic be higher in men than in women, for equivalent cigarette consumption, 48 and some studies have shown a greater effects of neutrophil cathepsin G, mast cell chymase, and chymotrypsin. Poller et al detected this deficiency relative loss of lung function in men than in women. 49 Others suggest that women may be more susceptible in four of 100 patients with COPD but in none of 100 healthy controls. 38 However, there seems to be a wide than men to the adverse effects of smoking on lung function. 50 Furthermore, some studies have suggested variation in the prevalence of this deficiency between different populations, 39 as is the case for 1 -antitrypsin that white males may be more prone to developing LEARNING POINTS * Only 10-20% of cigarette smokers develop symptomatic COPD, implying undue susceptibility compared with the remainder of the population at large. * Alpha 1 -antitrypsin deficiency, which is the only fully established genetic risk factor, accounts for less than 1% of all cases of COPD.
